Viewing Study NCT06965569


Ignite Creation Date: 2025-12-24 @ 11:03 PM
Ignite Modification Date: 2025-12-30 @ 5:27 PM
Study NCT ID: NCT06965569
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-28
First Post: 2025-04-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Multiple Ascending Dose Phase 1 Study of ALA-3000
Sponsor: Alar Pharmaceuticals Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module